Advances in Nanocarriers for Anticancer Drugs Delivery

被引:66
|
作者
Ali, Imran [1 ,2 ]
Lone, Mohammad Nadeem [1 ]
Suhail, Mohammad [1 ]
Mukhtar, Sofi Danish [1 ]
Asnin, Leonid [2 ]
机构
[1] Jamia Millia Islamia, Dept Chem, New Delhi 110025, India
[2] Perm Natl Res Polytech Univ, Perm, Russia
关键词
Current challenges; Future prospective; Mechanisms of action; Nano-anticancer drugs; Nanocarriers; Recent advances; TUMOR-TARGETED DELIVERY; MESOPOROUS SILICA NANOPARTICLES; ENHANCED ANTITUMOR EFFICACY; IN-VIVO EVALUATION; CARBON NANOTUBES; CONTROLLED-RELEASE; CANCER-THERAPY; CHITOSAN NANOPARTICLES; POLYMERIC NANOPARTICLES; CELLULAR UPTAKE;
D O I
10.2174/0929867323666160405111152
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cancer is the most dangerous disease to haunt the mankind in the world today. Generally, the overall cancer mortality rates are similar in both the sexes. The reasons for most of these deaths are inefficacy and failure of the current methods of treatments or the unavailability of treatment options. The researchers of the world are actively integrating nanotechnology of treating of various cancers. The development of smart nanocarriers is one of the most important innovations in this direction. The nanocarriers of the different materials are being developed to improve the efficacy of current treatments. The present article describes the role of nanotechnology in cancer treatment emphasizing cancer nanotherapy, nanocarriers for drug delivery, types and the mechanisms of the nanocarriers. Besides, the efforts are made to discuss the recent advances in the nanocarriers, current challenges and the future prospective.
引用
收藏
页码:2159 / 2187
页数:29
相关论文
共 50 条
  • [31] Pulmonary Delivery of Anticancer Drugs via Lipid-Based Nanocarriers for the Treatment of Lung Cancer: An Update
    Abdulbaqi, Ibrahim M.
    Abou Assi, Reem
    Yaghmur, Anan
    Darwis, Yusrida
    Mohtar, Noratiqah
    Parumasivam, Thaigarajan
    Saqallah, Fadi G.
    Wahab, Habibah A.
    PHARMACEUTICALS, 2021, 14 (08)
  • [32] Functional block copolymer nanocarriers for anticancer drug delivery
    Babikova, Dimitrina
    Kalinova, Radostina
    Zhelezova, Ivelina
    Momekova, Denitsa
    Konstantinov, Spiro
    Momekov, Georgi
    Dimitrov, Ivaylo
    RSC ADVANCES, 2016, 6 (88): : 84634 - 84644
  • [33] 'Nanodaisy' delivery of anticancer drugs
    Duc Le
    FUTURE MEDICINAL CHEMISTRY, 2014, 6 (11) : 1246 - 1246
  • [34] 'Nanodaisy' delivery of anticancer drugs
    Le, Duc
    NANOMEDICINE, 2014, 9 (09) : 1285 - 1285
  • [35] Hybrid nanocarriers for controlled delivery of antitumour and retroviral drugs delivery
    Horcajada, Patricia
    Serre, Christian
    Ferey, Gerard
    Couvreur, Patrick
    Gref, Ruxandra
    M S-MEDECINE SCIENCES, 2010, 26 (8-9): : 761 - 767
  • [36] Lipid nanoparticles for targeted delivery of anticancer therapeutics: Recent advances in development of siRNA and lipoprotein-mimicking nanocarriers
    Yaghmur, Anan
    Ostergaard, Jesper
    Mu, Huiling
    ADVANCED DRUG DELIVERY REVIEWS, 2023, 203
  • [37] Combination of microRNA therapeutics with small-molecule anticancer drugs: Mechanism of action and co-delivery nanocarriers
    Dai, Xin
    Tan, Chalet
    ADVANCED DRUG DELIVERY REVIEWS, 2015, 81 : 184 - 197
  • [38] Flavonoids: Recent Advances as Anticancer Drugs
    Liu, Hai L.
    Jiang, Wen B.
    Xie, Meng X.
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2010, 5 (02) : 152 - 164
  • [39] Advances in the development of hybrid anticancer drugs
    Fortin, Sebastien
    Berube, Gervais
    EXPERT OPINION ON DRUG DISCOVERY, 2013, 8 (08) : 1029 - 1047
  • [40] Multifunctional Liposome Nanocarriers Combining Upconverting Nanoparticles and Anticancer Drugs
    Huang, Yue
    Hemmer, Eva
    Rosei, Federico
    Vetrone, Fiorenzo
    JOURNAL OF PHYSICAL CHEMISTRY B, 2016, 120 (22): : 4992 - 5001